Complimentary Reports: Pharmaceutical Domain Management and Protecting Pharmaceutical Brands

With all the online challenges today's global pharmaceutical companies face -- illicit Internet pharmacies, gray-market drugs, trademark abuse and more -- it's simply too risky to complicate matters with a fragmented domain management process.

Learn what you're up against -- and how industry leader Novartis has successfully faced the same challenges -- in a pair of recently published reports from the enterprise brand protection experts at MarkMonitor.